Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 5, 2008, Pages 1373-1378

  Hasegawa, Takeshi ^a,b,c   Elder, Stacey J ^d   Bragg Gresham, Jennifer L ^d   Pisoni, Ronald L ^d   Yamazaki, Shin ^b   Akizawa, Tadao ^e   Jadoul, Michel ^f   Hugh, Rayner C ^g   Port, Friedrich K ^d   Fukuhara, Shunichi ^b  

^a Fujiyoshida Municipal Hospital   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^d ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^e SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^g BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

AGED; ARTERIOVENOUS SHUNT; ARTICLE; AUSTRALIA; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DRUG EFFECT; EUROPE; FEMALE; GASTROINTESTINAL HEMORRHAGE; GRAFT OCCLUSION; HUMAN; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NEW ZEALAND; NORTH AMERICA; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; TIME; VASCULAR PATENCY;

AGED; ARTERIOVENOUS SHUNT, SURGICAL; ASPIRIN; AUSTRALIA; EUROPE; FEMALE; GASTROINTESTINAL HEMORRHAGE; GRAFT OCCLUSION, VASCULAR; HUMANS; INCIDENCE; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEW ZEALAND; NORTH AMERICA; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; TIME FACTORS; VASCULAR PATENCY;

EID: 53749084806     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00130108     Document Type: Article

References (24)

1. Hakim R, Himmelfarb J: Hemodialysis access failure: a call to action. Kidney Int 54: 1029-1040, 1998
2. Rodriguez JA, Armadans L, Ferrer E, Olmos A, Codina S, Bartolome J, Borrellas J, Piera L: The function of permanent vascular access. Nephrol Dial Transplant 15: 402-408, 2000
3. Akiba T, Akizawa T, Fukuhara S, Saito A, Ohira S, Sekino H, Yamazaki C, Kishimoto T, Osawa G, Fujimi S, Marumo F, Kurokawa K, Bragg-Gresham JL, Pisoni RL, Port FK, Held PJ: Results of the international DOPPS hemodialysis, study in Japan. J Jpn Soc Dial Ther 37: 1865-1873, 2004
4. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ: Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61: 305-316, 2002
5. Sands JJ: Increasing AV fistulae and decreasing dialysis catheters: two aspects of improving patient outcomes. Blood Purif 25: 99-102, 2007
6. Stracke S, Konner K, Kostlin I, Friedl R, Jehle PM, Hombach V, Keller F, Waltenberger J: Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int 61: 1011-1019, 2002
7. Sterpetti AV, Cucina A, Santoro L, Cardillo B, Cavallaro A: Modulation of arterial smooth muscle cell growth by haemodynamic forces. Eur J Vasc Surg 6: 16-20, 1992
8. Himmelfarb J: Pharmacologic prevention of vascular access stenosis. Curr Opin Nephrol Hypertens 8: 569-572, 1999
9. Sreedhara R, Himmelfarb J, Lazarus JM, Hakim RM: Antiplatelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Kidney Int 45: 1477-1483, 1994
10. Kaufman JS, O'Connor TZ, Zhang JH, Cronin RE, Fiore LD, Ganz MB, Goldfarb DS, Peduzzi PN: Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol 14: 2313-2321, 2003
11. Saran R, Dykstra DM, Wolfe RA, Gillespie B, Held PJ, Young EW: Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 40: 1255-1263, 2002
12. Carvalho AC: Acquired platelet dysfunction in patients with uremia. Hematol Oncol Clin North Am 4:129-143, 1990
13. Wasse H, Gillen DL, Ball AM, Kestenbaum BR, Seliger SL, Sherrard D, Stehman-Breen CO: Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients. Kidney Int 64: 1455-1461, 2003
14. Ethier J, Bragg-Gresham JL, Piera L, Akizawa T, Asano Y, Mason N, Gillespie BW, Young EW: Aspirin prescription and outcomes in hemosialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 50: 602-611, 2007
15. Young EW, Goodkin DA, Mapes DL, Port FK, Keen ML, Chen K, Maroni BL, Wolfe RA, Held PJ: The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study. Kidney Int 57[Suppl]: 74-81, 2000
16. Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA: The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis 44: 7-15, 2004
17. Klein J, Moeschberger M: Survival Analysis Techniques for Censored and Truncated Data, New York, Springer, 1997, pp 416-418
18. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324: 71-86, 2002
19. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS: Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 137: 563-570, 2002
20. Reddan DN: Therapy for cardiovascular disease in patients with chronic kidney disease: appropriate caution or the absence of data. Am Heart J 144: 206-207, 2002
21. K/DOQI Workgroup: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45[Suppl]: 1-153. 2005
22. Weiss MF, Scivittaro V, Anderson JM: Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 37: 970-980, 2001
23. Grosser N, Schroder H: Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway. Arterioscler Thromb Vasc Biol 23: 1345-1351, 2003
24. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P: Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100: 793-798, 1999